CRISPR Therapeutics AG (CRSP)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 56.63 |
| Open | 56.64 |
| Bid | 55.31 x 600 |
| Ask | 55.41 x 200 |
| Day's range | 55.32 - 57.98 |
| 52-week range | 37.55 - 91.10 |
| Volume | |
| Avg. volume | 1,344,977 |
| Market cap | 4.703B |
| Beta (5Y monthly) | 1.77 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.70 |
| Earnings date | 08 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 84.29 |
ZacksCRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing
CRISPR Therapeutics AG (CRSP) closed at $56.63 in the latest trading session, marking a +1.22% move from the prior day.
ZacksIs Most-Watched Stock CRISPR Therapeutics AG (CRSP) Worth Betting on Now?
Zacks.com users have recently been watching CRISPR Therapeutics (CRSP) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
ZacksCRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note
CRISPR Therapeutics AG (CRSP) reachead $59.60 at the closing of the latest trading day, reflecting a -1.6% change compared to its last close.
© 2024 Yahoo. All rights reserved.